Literature DB >> 557760

Inverse cerebellum and occipital encephalocele. A dorsal fusion defect uniting the Arnold-Chiari and Dandy-Walker spectrum.

M T Smith, H W Huntington.   

Abstract

The malformation of inverse cerebellum and occipital encephalocele is situated morphologically between the Arnold-Chiari and Dandy-Walker malformations. In the three reported cases, hydrocephalus was not present, concomitant malformations of the lamina terminalis were present in two, and polymicrogyria was found in all three. The primary defect in the malformation is a complex occipital encephalocele composed of miniature hemispheres connected to the brain stem by an extension of the midbrain tectum. The cerebellar folia extend ventrally and cover the basilar artery. We propose that the encephalocele arises through the processes of overgrowth and dysraphism and thus falls into the organogenetic malformations of Yakovlev. Supporting this theory is the consistent observation of the duplicate hemispheres in the encephalocele and the hydromyelia in the examined spinal cords.

Entities:  

Mesh:

Year:  1977        PMID: 557760     DOI: 10.1212/wnl.27.3.246

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Uncommon posterior cranial fossa anomalies: MRI with clinical correlation.

Authors:  P Demaerel; B E Kendall; G Wilms; S F Halpin; P Casaer; A L Baert
Journal:  Neuroradiology       Date:  1995-01       Impact factor: 2.804

2.  Agenesis of the vermis with fusion of the cerebellar hemispheres, septo-optic dysplasia and associated anomalies. Report of a case.

Authors:  J Michaud; E M Mizrahi; H Urich
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

3.  Occipital extra- and intracranial lipoencephalocele associated with tectocerebellar dysraphia.

Authors:  Amir R Dehdashti; Hana Abouzeid; Shahan Momjian; Jacqueline Delavelle; Bénédict Rilliet
Journal:  Childs Nerv Syst       Date:  2004-02-17       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.